ID26965A - Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid - Google Patents

Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid

Info

Publication number
ID26965A
ID26965A IDW20002095A ID20002095A ID26965A ID 26965 A ID26965 A ID 26965A ID W20002095 A IDW20002095 A ID W20002095A ID 20002095 A ID20002095 A ID 20002095A ID 26965 A ID26965 A ID 26965A
Authority
ID
Indonesia
Prior art keywords
breast cancer
aromatase
medicine
prevent
treat breast
Prior art date
Application number
IDW20002095A
Other languages
English (en)
Inventor
Alfred Schmidt
Heinrich Wieland
Original Assignee
S W Patentverwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID26965(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S W Patentverwertungs Gmbh filed Critical S W Patentverwertungs Gmbh
Publication of ID26965A publication Critical patent/ID26965A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20002095A 1998-03-18 1999-03-03 Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid ID26965A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (de) 1998-03-18 1998-03-18 Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen

Publications (1)

Publication Number Publication Date
ID26965A true ID26965A (id) 2001-02-22

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002095A ID26965A (id) 1998-03-18 1999-03-03 Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid

Country Status (19)

Country Link
EP (2) EP0943333A1 (id)
JP (1) JP4920822B2 (id)
KR (1) KR100778803B1 (id)
CN (1) CN1168448C (id)
AT (1) ATE230995T1 (id)
AU (1) AU751040B2 (id)
BR (1) BR9908885A (id)
CA (1) CA2324077C (id)
CZ (1) CZ292643B6 (id)
DE (1) DE59904042D1 (id)
DK (1) DK1063998T3 (id)
ES (1) ES2190201T3 (id)
HU (1) HU226105B1 (id)
ID (1) ID26965A (id)
IL (1) IL138292A (id)
PL (1) PL343100A1 (id)
RU (1) RU2225206C2 (id)
SK (1) SK285349B6 (id)
WO (1) WO1999047143A1 (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
RU2297798C1 (ru) * 2005-10-03 2007-04-27 Государственное учреждение научно-исследовательский институт онкологии Томского Научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ онкологии ТНЦ СО РАМН Способ комплексного лечения резектабельных форм рака эндометрия
RU2363466C2 (ru) * 2007-03-29 2009-08-10 АО Ефаг Способ и набор для лечения и профилактики злокачественных опухолей женской репродуктивной системы с применением 9-оксоакридин-10-уксусной кислоты, и/или ее соли, и/или ее сложного эфира
JP4524296B2 (ja) * 2007-03-30 2010-08-11 生化学工業株式会社 発毛促進剤
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
RU2396942C2 (ru) * 2008-08-01 2010-08-20 Владимир Борисович Деев Лекарственная композиция для лечения доброкачественных новообразований на коже
KR20140040690A (ko) * 2011-01-31 2014-04-03 루콜라스-엠.디. 리미티드 미용학적 용도
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
EP2648721B1 (de) * 2011-01-31 2018-09-19 LUCOLAS-M.D. Ltd. Kombinationen von aromatase inhibitoren und antioxidanzien
EP3666276A1 (en) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JPS6345294A (ja) * 1986-04-07 1988-02-26 Shionogi & Co Ltd アロマタ−ゼ阻害ステロイド誘導体
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
GB2231568B (en) * 1989-03-31 1992-07-08 Farmos Oy New aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
FR2656310B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
DE69427289T2 (de) * 1993-03-16 2001-09-06 Pfizer Inc., New York Naphtalinderivate
JPH07215992A (ja) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd ６−又は７−置換アンドロスタ−１，４−ジエン誘導体
DE69519582D1 (de) * 1994-09-14 2001-01-11 Univ Sheffield Kontrolle des haarwuchses
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
ATE200978T1 (de) * 1996-03-29 2001-05-15 S W Patentverwertungs Ges M B KOSMETIKUM BZW. KOSMETIKZUSAMMENSETZUNG ZUR GLÄTTUNG UND STRAFFUNG DER HAUT BEI GESTÖRTEM UNTERHAUT-BINDE-FETTGEWEBE, INSBESONDERE BEI DER ßCELLULITEß
CA2632790A1 (en) * 1996-07-22 1998-01-29 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders

Also Published As

Publication number Publication date
SK285349B6 (sk) 2006-11-03
AU3143499A (en) 1999-10-11
CA2324077A1 (en) 1999-09-23
CN1168448C (zh) 2004-09-29
IL138292A (en) 2005-08-31
ES2190201T3 (es) 2003-07-16
EP1063998B1 (de) 2003-01-15
ATE230995T1 (de) 2003-02-15
SK13422000A3 (sk) 2001-05-10
BR9908885A (pt) 2000-11-21
CZ292643B6 (cs) 2003-11-12
EP1063998A1 (de) 2001-01-03
RU2225206C2 (ru) 2004-03-10
PL343100A1 (en) 2001-07-30
WO1999047143A1 (de) 1999-09-23
HU226105B1 (en) 2008-04-28
DE59904042D1 (de) 2003-02-20
CN1301165A (zh) 2001-06-27
JP2002506823A (ja) 2002-03-05
CA2324077C (en) 2008-07-29
EP0943333A1 (de) 1999-09-22
IL138292A0 (en) 2001-10-31
KR20010034603A (ko) 2001-04-25
DK1063998T3 (da) 2003-05-12
JP4920822B2 (ja) 2012-04-18
KR100778803B1 (ko) 2007-11-27
AU751040B2 (en) 2002-08-08
CZ20003256A3 (cs) 2001-04-11
HUP0101005A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
PL365285A1 (en) Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
BR0315597A (pt) Processos de baixa dose para tratamento de distúrbios em que a atividade de tnf(alfa)é prejudicial
BR9908592A (pt) Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
BR9806060A (pt) Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina.
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
MXPA04000654A (es) Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
ID26965A (id) Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid
BG100510A (en) Method of treating androgenic alopecia with 5-alpha reductase inhibitors
MY164077A (en) Compositions and uses of et743 for treating cancer
GB0020504D0 (en) Therapeutic method
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
AU2003250190A1 (en) Combination of an aromatase inhibitor with a bisphosphonate
HUP9901505A2 (hu) Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására
DE60030107D1 (de) Vitamin-d derivate zur behandlung des systemischen lupus erythematodes
NZ511559A (en) Use of staurosporine derivatives for treating ocular neovascular diseases
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
BR0115215A (pt) Método para o tratamento de inflamações
ATE293972T1 (de) Behandlung von chronischen schmerzen
PL367707A1 (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
BR0111740A (pt) Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação
RU94044457A (ru) Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин
BR0315374A (pt) Compostos orgânicos
NZ337048A (en) Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer